Tor Biering-sørensen
Clinical trials sponsored by Tor Biering-sørensen, explained in plain language.
-
Massive trial tests COVID shot in healthy Middle-Aged adults
⭐️ VACCINE ⭐️ OngoingThis study tests whether a COVID-19 vaccine (mRNA-1273) can prevent severe COVID-19 in healthy adults aged 50 to 64. About 285,000 participants will be randomly assigned to get the vaccine or not. The goal is to see if the vaccine reduces hospitalizations and other serious outcom…
Phase: PHASE4 • Sponsor: Tor Biering-Sørensen • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 17, 2026 00:43 UTC
-
Massive RSV vaccine trial aims to slash hospitalizations in adults
⭐️ VACCINE ⭐️ OngoingThis large study tests whether the Abrysvo RSV vaccine can prevent hospitalizations due to RSV in adults aged 18 and older. About 690,000 participants are randomly assigned to receive either the vaccine or no vaccine. The main goal is to see if the vaccine reduces the number of p…
Phase: PHASE4 • Sponsor: Tor Biering-Sørensen • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:05 UTC